Chronic Kidney Disease News

The National Kidney Foundation recently hosted a live event, as a part of its NKF Live series, to discuss uremic pruritus.

In middle-aged women, kidney function declined slower than it did in men the same age or older during aging, according to a study in the Journal of the American Society of Nephrology.

The American Diabetes Association and Kidney Disease: Improving Global Outcomes have released a consensus report addressing diabetes management in chronic kidney disease.

Among adults with nonvalvular atrial fibrillation, direct oral anticoagulant initiation was associated with lower risk for renal failure or progression of chronic kidney disease compared with vitamin K antagonist initiation, data show.

Both BNT162b2 and CoronaVac vaccines protected patients with chronic kidney disease from COVID-19-related hospitalization and mortality, according to data published in Kidney International.

The FDA granted investigational new drug clearance to Transcenta Holding Limited for TST004, its humanized monoclonal antibody that attacks the enzyme contributing to IgA nephropathy development, according to a press release.

Remdesivir treatment reduced risks for mortality, high-flow nasal cannula use and transfer to the ICU among patients on hemodialysis hospitalized with COVID-19, according to a study in Kidney International Reports.

Study results published in Diabetes Care highlight the importance of maintaining HbA1c lower than 7% to avoid proliferative diabetic retinopathy and macroalbuminuria for people with type 1 diabetes.

Infants with severe congenital anomalies of the kidney and urinary tract, including those who do not require dialysis, are at risk for early growth failure, according to data published in the Journal of Renal Nutrition.

The FDA has granted orphan drug designation to PXL770, a first-in-class direct adenosine monophosphate-activated protein kinase activator designed by Poxel to treat autosomal-dominant polycystic kidney disease, according to a press release.